Magnus Financial Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
TE
SI
SFA
PR
GI
FFA
Magnus Financial Group's IMNM Position: Q2 2026 in Review
Magnus Financial Group reduced its Immunome (IMNM) stake by 8.7% in Q2 2026, selling an estimated $85.6K and leaving 41,759 shares worth $885K. The position accounts for 0.06% of the portfolio, ranked #175.
Magnus Financial Group first reported a position in IMNM in Q1 2021 and has held it in 22 quarters since. The position peaked at $1M in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.
- Magnus Financial Group held 41,759 shares of Immunome worth $885K as of Q2 2026.
- Magnus Financial Group sold 4,000 Immunome shares in Q2 2026, an estimated $85.6K.
- Immunome made up 0.06% of Magnus Financial Group's portfolio in Q2 2026, its #175 holding.
- Magnus Financial Group first reported a position in Immunome in Q1 2021 and has held it in 22 quarters since.
- Magnus Financial Group's Immunome position peaked at $1M in Q1 2026.
- 7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.
Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.